Recent developments in melanoma with brain metastases

Recent developments in melanoma with brain metastases

VJOncology

1 year
57 Views
Share
Want to watch this again later?
Sign in to add this video to a playlist. Login
0 0
Category:
Description:
While treatments for melanoma have been steadily improving over recent years, patients with brain metastases have consistently had poor outcomes. In this video, recorded at the American Society of Oncology (ASCO) 2018 Annual Meeting, held in Chicago, IL, Grant McArthur, MBBS, BMedSc, PhD, FRACP, of the Peter MacCallum Cancer Centre, Melbourne, Australia, discusses recent developments in targeted therapy and immunotherapy, which might improve these patients prognoses. He outlines the biology of melanoma brain metastases that make these therapies possible: disruption of the blood-brain barrier and tumor infiltration of CD8 T-cells improves efficacy of targeted therapies and immune checkpoint therapies. Dr McArthur finally describes some recent trial data, which prove these concepts and show an increased median survival: a definite step in the right direction.
Up Next Autoplay
Investigational Melanoma Vaccine, Seviprotimut-L: Moving Forward
Investigational Melanoma Vaccine, Seviprotimut-L: Moving Forward
Category: Melanoma and Skin Cancer
9 Views
UVA Cancer Center 2 months
Phase III Data for Investigational Melanoma Vaccine, Seviprotimut-L #SITC @UVACancerCenter
Phase III Data for Investigational Melanoma Vaccine, Seviprotimut-L #SITC @UVACancerCenter
Category: Melanoma and Skin Cancer
28 Views
UVA Cancer Center 2 months
Annual meeting of the Society for Immunotherapy of Cancer (SITC) 2019 Polynoma Presenting Interim Phase III Evidence for Its Investigational Melanoma Vaccine, Seviprotimut-L
Annual meeting of the Society for Immunotherapy of Cancer (SITC) 2019 Polynoma Presenting Interim Phase III Evidence for Its Investigational Melanoma Vaccine, Seviprotimut-L
Category: Melanoma and Skin Cancer
40 Views
Cancer-News 2 months
Dual-function Virus Designed For Killing Tumor Cells and Helping Immune Cells
Dual-function Virus Designed For Killing Tumor Cells and Helping Immune Cells
Category: Melanoma and Skin Cancer
35 Views
Cancer-News 3 months
Will the CheckMate 204 data affect clinicians?
Will the CheckMate 204 data affect clinicians?
Category: Melanoma and Skin Cancer
19 Views
moasc 4 months
CheckMate 204 Study
CheckMate 204 Study
Category: Melanoma and Skin Cancer
23 Views
moasc 4 months
Clinicians could change the way they manage their patients
Clinicians could change the way they manage their patients
Category: Melanoma and Skin Cancer
4 Views
moasc 4 months
Fixing toxic therapy
Fixing toxic therapy
Category: Melanoma and Skin Cancer
8 Views
moasc 4 months
Alternate dosing for immunotherapy
Alternate dosing for immunotherapy
Category: Melanoma and Skin Cancer
4 Views
moasc 4 months
Is this data practice changing for clinicians?
Is this data practice changing for clinicians?
Category: Melanoma and Skin Cancer
4 Views
moasc 4 months